IGA NEPHROPATHY (IGAN)
Clinical trials for IGA NEPHROPATHY (IGAN) explained in plain language.
Never miss a new study
Get alerted when new IGA NEPHROPATHY (IGAN) trials appear
Sign up with your email to follow new studies for IGA NEPHROPATHY (IGAN), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Ancient herbal formula tested in modern fight against kidney disease
Disease control Not yet recruitingThis study aims to find out if a traditional Chinese herbal formula called Shenqi Yishen Granules can help treat IgA nephropathy, a type of kidney disease. Researchers will enroll 102 adults with early-stage disease to see if the granules reduce protein in their urine better than…
Matched conditions: IGA NEPHROPATHY (IGAN)
Phase: NA • Sponsor: Keda Lu • Aim: Disease control
Last updated Mar 23, 2026 15:16 UTC
-
First human test for kidney disease drug seeks safety clues
Knowledge-focused Not yet recruitingThis is an early safety study for a new injection called RG002C0106, which is being developed for IgA nephropathy, a kidney disease. The main goal is to see how the drug is processed by the body in people with healthy kidneys compared to those with mild or moderate kidney problem…
Matched conditions: IGA NEPHROPATHY (IGAN)
Phase: PHASE1 • Sponsor: Rigerna Therapeutics Co., Ltd.; Rigerna Therapeutics (Beijing) Co., Ltd. • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:30 UTC